Perilymphatic atrophy of the skin. A side effect of topical corticosteroid injection therapy

1974 ◽  
Vol 109 (4) ◽  
pp. 558-559 ◽  
Author(s):  
I. Kikuchi
1975 ◽  
Vol 92 (6) ◽  
pp. 689-691 ◽  
Author(s):  
P.J.A. HOLT ◽  
R. MARKS ◽  
E. WADDINGTON

1999 ◽  
Vol 69 (9) ◽  
pp. 655-659 ◽  
Author(s):  
Nisar Ahmad Chowdri ◽  
Mohammad Masarat Ajaz Mattoo ◽  
Mohammad Ashraf Darzi

2020 ◽  
Vol 12 (3) ◽  
Author(s):  
Vilhjalmur Finsen ◽  
Ante Kalstad ◽  
Rainer G. Knobloch

Pain while sitting is the most common complaint among patients with Coccydynia. In young patients this may seriously affect their schooling which usually involves long periods of sitting. We studied if this improved after either injection therapy or surgery. During a seven-year period 32 adolescents with a mean age of 15 (range: 11-17) years were treated in our department because of coccydynia. They were followed up with mailed questionnaires at a minimum of 12 months after treatment and 28 (88%) responded. Three were no longer attending school and were excluded. Of the remainder, 12 received only injection therapy while 13 were operated upon. Mean follow-up time was 36 (14-66) months. Eight reported absence from school during the month before treatment, but only one during the week before review (p<0.01). There was significant improvement in sitting during class and physical exercise at school and when engaging in general sports (p<0.01). We can not exclude that improvements would have occurred spontaneously, but this seems unlikely as symptoms had persisted for more than two years before treatment. We conclude that in juveniles, an additional benefit of treating coccydynia with corticosteroid injection or operative resection is that their ability to attend school and take part in sports improves significantly.


2020 ◽  
Vol 9 (1) ◽  
pp. 43-48
Author(s):  
Amir Bajracharya

Background: Ear keloid is one of the challenging problems that affect people of different races with substantial aesthetic outcomes. Various types of treatment modalities, including intralesional corticosteroid injection are advocated to lower recurrence following excision. Objectives: To investigate the efficacy of a combined excision and postoperative intralesional triamcinolone acetonide (TA) injection for treating ear keloid patients. Methodology: This was a descriptive study done to observe the outcome of combined approach of surgical and intra-lesional steroids injection therapy for ear keloids. Age, sex, site, size, duration, recurrence, and aesthetic outcome were evaluated. Results: A total of 18 patients representing 19 ear keloids, with one case having bilateral and 3 pediatric cases were included from February 2018 to January 2019.The mean age was 22 years with female to male ratio of 5:1, site were left sided 9 (50%), right 8 (44%) and 1(6%) bilateral. About 10 (53%) cases were at helix, and 9(47%) at ear lobule. Mean length of ear keloid was 1.53 cm with range of 0.5-3cm and mean breath 1.39cm with the range of 0.5-2.5 cm. The mean duration of ear keloid was 9.47 months. 2 (11%) cases showed a history of recurrence. Injection triamcinolone acetonide hypersensitivity was noted by 1 (5.3%) patient. Evaluation for all patients with aesthetic outcome was mean ± standard deviation (4.38±1.025). Conclusion: Management of ear keloid using the combination of surgical excision and intra-lesional steroids injection therapy can be a good alternative option with low recurrence rate.


Orbit ◽  
1985 ◽  
Vol 4 (3) ◽  
pp. 177-181 ◽  
Author(s):  
G. Bonavolont ◽  
P. Vassallo ◽  
G. Uccello ◽  
F. Tranfa

2021 ◽  
Vol 5 (11) ◽  
pp. 988-996
Author(s):  
Abla Ghanie ◽  
Listya Paramita ◽  
Fiona Widyasari ◽  
Ahmad Hifni ◽  
Erial Bahar

Background. Sudden deafness is an emergency in the Ear Nose Throat Department, a subset of sensorineural hearing loss within a 72-hour window period and consists of a decrease in hearing of 30 decibels affecting at least three consecutive frequencies. The therapy given is corticosteroids, systemic corticosteroids or intratympanic corticosteroids injection, or both. The prognosis of sudden deafness depends on several factors. Patient with sudden hearing loss does not always have the same result in hearing improvement. This study was aimed to determine the factors that affect the results of intratympanic corticosteroid injection therapy in patients with sudden deafness.Methods. This study is an observational study with a cross-sectional design. The data were collected using medical records on 96 ears given intratympanic corticosteroid injection therapy at Dr. Mohammad Hoesin Hospital Palembang from July 2018 to February 2021.Results. From 96 ears conducted in the study, the improvement of therapeutic results on intratympanic corticosteroid injection in patients with sudden deafness was 72.9%. The study found factors that influenced the outcome of therapy, namely age (p=0.002), the onset of therapy (p = 0.003), and the use of a combination of systemic steroids (p=0.010). From the logistic regression test, it was found that the factors that most influenced the results of intratympanic corticosteroid injection therapy were young age 18-40 years (p=0.016) with (OR) 6.654 (CI95% 1.418-31.222) and therapy onset less than two weeks (p=0.027) with (OR) 3.108 (95% CI 1.134-8.515).Conclusions. The factors associated with the improvement in the outcome of intratympanic corticosteroid injection therapy in patients with sudden hearing loss were patient age and early onset of therapy.


Hand ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. 439-444 ◽  
Author(s):  
Cornelius Schubert ◽  
Helen G. Hui-Chou ◽  
Alfred P. See ◽  
E. Gene Deune

Sign in / Sign up

Export Citation Format

Share Document